General Information of This Drug (ID: DM2570B)

Drug Name
Poly-ICLC   DM2570B
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Glioblastoma multiforme DISK8246 2A00.0 Phase 2 [1]
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models. J Transl Med. 2007 Feb 12;5:10.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)